EN
HI
Summary
As of 31 Oct, 2026, Astrazeneca Pharma India stock price is ₹6364.5. During the trading session, the stock has moved between an intraday low of ₹6240.50 and an intraday high of ₹6380.00. Over the last 52 weeks, Astrazeneca Pharma India has traded between ₹5640.00 and ₹9849.50.
The stock has recorded a trading volume of 6,845 shares,. Its Average Traded Price (ATP) is ₹6319.88, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹6364.50.
Astrazeneca Pharma India has an upper circuit limit of ₹7558.50 and a lower circuit limit of ₹5039.50. The total value traded stands at ₹4.33 CR, and the delivery percentage for the day is 39.38%.
The stock is currently traded with a market lot size of 1. Astrazeneca Pharma India also offers a dividend yield of 0%.
Astrazeneca Pharma India Share Price Chart
Astrazeneca Pharma India Share Key Metrics
Volume
6845.00
Market Cap
15911.25 CR
LTQ@LTP
1@6364.50
ATP
6319.88
Var Margin
14.52 %
Circuit Range
5039.5-7558.5
Delivery %
39.38 %
Value
4.33 CR
ASM/GSM
No
Market Lot
1
Astrazeneca Pharma India Resistance and Support
Pivot 6279.83
Resistance
First Resistance
6389.66
Second Resistance
6480.33
Third Resistance
6590.16
Support
First Support
6189.16
Second Support
6079.33
Third Support
5988.66
Astrazeneca Pharma India Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 6300 | 6364.5 | 1.04% | 6380 | 6240.5 |
| Thu Oct 29 2026 | 6185.5 | 6299 | 0.99% | 6370.5 | 6170 |
| Wed Oct 28 2026 | 6069.5 | 6237 | 2.70% | 6400 | 6042.5 |
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Astrazeneca Pharma India News
AstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday, November 5, 2026
AstraZeneca Pharma board to meet on 5 Nov 2026 for financial results.
Oct 30 2026 14:38:14
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairperson |
| Revathy Ashok | Non Executive Independent Director |
Astrazeneca Pharma India Similar Stocks
Acutaas Chemicals Ltd.
4003.60
26.90 (0.68%)
Krishna Institute of Medical Sciences Ltd
701.80
-0.70 (0.10%)
Rubicon Research Ltd.
1610.50
51.20 (3.28%)
Neuland Laboratories Ltd.
19700.00
420.00 (2.18%)
Granules India Ltd.
839.75
2.40 (0.29%)
Cohance Lifesciences Ltd.
444.30
-37.05 (7.70%)
Shilpa Medicare Ltd.
955.60
20.00 (2.14%)
Onesource Specialty Pharma Ltd.
1563.00
-6.60 (0.42%)
Caplin Point Laboratories Ltd.
2325.60
-50.50 (2.13%)
Pfizer Ltd.
3687.80
-72.00 (1.91%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 6364.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 39.93 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 15911.25 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 9849.50 & 5640.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASTRAZEN
